Retatrutide vs MOTS-C
How the two compare on paper. Both come pre-filled in a pen with a lab report per batch.
| Retatrutide | MOTS-C | |
|---|---|---|
| Research area | Metabolic | Longevity |
| What it is | Triple GIP / GLP-1 / glucagon receptor agonist. | Mitochondrial-derived peptide. |
| Researched | for energy expenditure | for mitochondrial signalling |
| Strengths | 10 mg, 20 mg, 40 mg, 10 mg, 20 mg, 60 mg | 10 mg, 30 mg, 40 mg, 10 mg |
| From | AED 605 | AED 165 |
| Price per mg | AED 48/mg | AED 17/mg |
| Lab report purity | 99.70% (batch AP26-4458) | 99.66% (batch AP26-4477) |
| What researchers look at | Incretin receptor pharmacology, Energy-expenditure models, Triple-agonism selectivity | AMPK activation, Mitochondrial signalling, Metabolic homeostasis |
Why they are researched together
Retatrutide acts at receptors on the cell surface; MOTS-C is encoded inside the mitochondrion. Energy-expenditure models frequently need a handle on both the signalling and the organelle.